{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:02Z","timestamp":1791928682834,"version":"4.3.4"},"reference-count":30,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,5,22]]},"DOI":"10.1167\/iovs.17-23223","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T15:33:37Z","timestamp":1527694417000},"page":"2548","source":"Crossref","is-referenced-by-count":12,"title":["FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost"],"prefix":"10.1167","volume":"59","author":[{"given":"Lance P.","family":"Doucette","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Footz","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-6-2548-b01","doi-asserted-by":"crossref","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90: 262\u2013267.","DOI":"10.1136\/bjo.2005.081224"},{"key":"i1552-5783-59-6-2548-b02","doi-asserted-by":"crossref","unstructured":"Doucette LP, Rasnitsyn A, Seifi M, Walter MA. The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol. 2015; 60: 310\u2013326.","DOI":"10.1016\/j.survophthal.2015.01.004"},{"key":"i1552-5783-59-6-2548-b03","doi-asserted-by":"crossref","unstructured":"Doucette LP, Walter MA. Prostaglandins in the eye: function, expression, and roles in glaucoma. Ophthalmic Genet. 2017; 38: 108\u2013116.","DOI":"10.3109\/13816810.2016.1164193"},{"key":"i1552-5783-59-6-2548-b04","doi-asserted-by":"crossref","unstructured":"Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972; 240: 200\u2013203.","DOI":"10.1038\/newbio240200a0"},{"key":"i1552-5783-59-6-2548-b05","doi-asserted-by":"crossref","unstructured":"Feigenson M, Eliseev RA, Jonason JH, Mills BN, O'Keefe RJ. PGE2 receptor subtype 1 (EP1) regulates mesenchymal stromal cell osteogenic differentiation by modulating cellular energy metabolism. J Cell Biochem. 2017; 118: 4383\u20134393.","DOI":"10.1002\/jcb.26092"},{"key":"i1552-5783-59-6-2548-b06","doi-asserted-by":"crossref","unstructured":"Jin D, Ni TT, Sun J, et al. Prostaglandin signalling regulates ciliogenesis by modulating intraflagellar transport. Nat Cell Biol. 2014; 16: 841\u2013851.","DOI":"10.1038\/ncb3029"},{"key":"i1552-5783-59-6-2548-b07","doi-asserted-by":"crossref","unstructured":"Tam AL, Gupta N, Zhang Z, Yucel YH. Latanoprost stimulates ocular lymphatic drainage: an in vivo nanotracer study. Trans Vis Sci Tech. 2013; 2 (5): 3.","DOI":"10.1167\/tvst.2.5.3"},{"key":"i1552-5783-59-6-2548-b08","doi-asserted-by":"crossref","unstructured":"Seifi M, Walter MA. Axenfeld-Rieger syndrome [published online ahead of print October 3, 2017]. Clin Genet. doi:10.1111\/cge.13148.","DOI":"10.1111\/cge.13148"},{"key":"i1552-5783-59-6-2548-b09","doi-asserted-by":"crossref","unstructured":"Strungaru MH, Dinu I, Walter MA. Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations. Invest Ophthalmol Vis Sci. 2007; 48: 228\u2013237.","DOI":"10.1167\/iovs.06-0472"},{"key":"i1552-5783-59-6-2548-b10","doi-asserted-by":"crossref","unstructured":"Tamimi Y, Lines M, Coca-Prados M, Walter MA. Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment. Invest Ophthalmol Vis Sci. 2004; 45: 3904\u20133913.","DOI":"10.1167\/iovs.04-0628"},{"key":"i1552-5783-59-6-2548-b11","unstructured":"Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979; 18: 1043\u20131049."},{"key":"i1552-5783-59-6-2548-b12","doi-asserted-by":"crossref","unstructured":"Rasnitsyn A, Doucette L, Seifi M, Footz T, Raymond V, Walter MA. FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25. PLoS One. 2017; 12: e0178518.","DOI":"10.1371\/journal.pone.0178518"},{"key":"i1552-5783-59-6-2548-b13","doi-asserted-by":"crossref","unstructured":"Li X, He F, Gabelt BT, et al. Effects of latanoprost and bimatoprost on the expression of molecules relevant to ocular inflow and outflow pathways. PLoS One. 2016; 11: e0151644.","DOI":"10.1371\/journal.pone.0151644"},{"key":"i1552-5783-59-6-2548-b14","doi-asserted-by":"crossref","unstructured":"Saleem RA, Banerjee-Basu S, Berry FB, Baxevanis AD, Walter MA. Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1. Am J Hum Genet. 2001; 68: 627\u2013641.","DOI":"10.1086\/318792"},{"key":"i1552-5783-59-6-2548-b15","doi-asserted-by":"crossref","unstructured":"Alexander CL, Miller SJ, Abel SR. Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann Pharmacother. 2002; 36: 504\u2013511.","DOI":"10.1345\/aph.1A178"},{"key":"i1552-5783-59-6-2548-b16","doi-asserted-by":"crossref","unstructured":"Stamer WD, Piwnica D, Jolas T, et al. Cellular basis for bimatoprost effects on human conventional outflow. Invest Ophthalmol Vis Sci. 2010; 51: 5176\u20135181.","DOI":"10.1167\/iovs.09-4955"},{"key":"i1552-5783-59-6-2548-b17","unstructured":"Lee PY, Shao H, Xu LA, Qu CK. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects. Invest Ophthalmol Vis Sci. 1988; 29: 1474\u20131477."},{"key":"i1552-5783-59-6-2548-b18","doi-asserted-by":"crossref","unstructured":"Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268\u20131279.","DOI":"10.1001\/archopht.120.10.1268"},{"key":"i1552-5783-59-6-2548-b19","doi-asserted-by":"crossref","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998; 126: 487\u2013497.","DOI":"10.1016\/S0002-9394(98)00223-2"},{"key":"i1552-5783-59-6-2548-b20","doi-asserted-by":"crossref","unstructured":"Ota T, Aihara M, Saeki T, Narumiya S, Araie M. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Invest Ophthalmol Vis Sci. 2006; 47: 3395\u20133399.","DOI":"10.1167\/iovs.06-0100"},{"key":"i1552-5783-59-6-2548-b21","doi-asserted-by":"crossref","unstructured":"Hinz B, Rosch S, Ramer R, Tamm ER, Brune K. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J. 2005; 19: 1929\u20131931.","DOI":"10.1096\/fj.04-3626fje"},{"key":"i1552-5783-59-6-2548-b22","doi-asserted-by":"crossref","unstructured":"Yu AL, Fuchshofer R, Kampik A, Welge-Lussen U. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Invest Ophthalmol Vis Sci. 2008; 49: 4872\u20134880.","DOI":"10.1167\/iovs.07-0984"},{"key":"i1552-5783-59-6-2548-b23","doi-asserted-by":"crossref","unstructured":"Elian FA, Yan E, Walter MA. FOXC1, the new player in the cancer sandbox. Oncotarget. 2018; 9: 8165\u20138178.","DOI":"10.18632\/oncotarget.22742"},{"key":"i1552-5783-59-6-2548-b24","doi-asserted-by":"crossref","unstructured":"Xu YZ, Chen FF, Zhang Y, et al. The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma. Tumour Biol. 2017; 39: 1010428317706054.","DOI":"10.1177\/1010428317706054"},{"key":"i1552-5783-59-6-2548-b25","doi-asserted-by":"crossref","unstructured":"Kong XP, Yao J, Luo W, et al. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Mol Cell Biochem. 2014; 394: 177\u2013186.","DOI":"10.1007\/s11010-014-2093-4"},{"key":"i1552-5783-59-6-2548-b26","doi-asserted-by":"crossref","unstructured":"Norrdin RW, Jee WS, High WB. The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids. 1990; 41: 139\u2013149.","DOI":"10.1016\/0952-3278(90)90081-U"},{"key":"i1552-5783-59-6-2548-b27","doi-asserted-by":"crossref","unstructured":"Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970; 86: 1436\u20131440.","DOI":"10.1210\/endo-86-6-1436"},{"key":"i1552-5783-59-6-2548-b28","doi-asserted-by":"crossref","unstructured":"Lerner UH. Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption. J Bone Miner Res. 1987; 2: 375\u2013383.","DOI":"10.1002\/jbmr.5650020504"},{"key":"i1552-5783-59-6-2548-b29","doi-asserted-by":"crossref","unstructured":"Garrett IR, Mundy GR. Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria. J Bone Miner Res. 1989; 4: 789\u2013794.","DOI":"10.1002\/jbmr.5650040520"},{"key":"i1552-5783-59-6-2548-b30","doi-asserted-by":"crossref","unstructured":"Bailey JN, Loomis SJ, Kang JH, et al. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat Genet. 2016; 48: 189\u2013194.","DOI":"10.1038\/ng.3482"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2682569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:53Z","timestamp":1791927053000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.17-23223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.17-23223","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,22]]}}}